Cargando…
Prognostic nutritional index predicts the prognosis of patients with advanced esophageal cancer treated with immune checkpoint inhibitors: a retrospective cohort study
BACKGROUND: Immune checkpoint inhibitors (ICIs) play an important role in the treatment of esophageal cancer (EC). However, their efficacy is variable, and there are still no effective and convenient biomarkers to identify and assess their efficacy. In recent years, programmed cell death-ligand 1 (P...
Autores principales: | Wu, Mengjing, Zhu, Yunyun, Chen, Xiancheng, Wang, Xinpeng, Lin, Xinyue, Yan, Xue, Mo, Peng, Ye, Ying, Zeng, Yanjing, Yang, Yanyong, Fu, Zhichao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007954/ https://www.ncbi.nlm.nih.gov/pubmed/36915449 http://dx.doi.org/10.21037/jgo-23-48 |
Ejemplares similares
-
Real-world experience with anti–programmed cell death protein 1 immunotherapy in patients with esophageal cancer: A retrospective single-center study
por: Wang, Xinpeng, et al.
Publicado: (2022) -
Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors
por: Zhang, Lilong, et al.
Publicado: (2023) -
Prognostic Nutritional Index Predicts Response and Prognosis in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Ni, Liwei, et al.
Publicado: (2022) -
Prognostic Effect of the Controlling Nutritional Status Score in Patients With Esophageal Cancer Treated With Immune Checkpoint Inhibitor
por: Chang, Lele, et al.
Publicado: (2022) -
The role of pretreatment prognostic nutritional index in esophageal cancer: A meta‐analysis
por: Xue, Yibo, et al.
Publicado: (2019)